Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

NCT05673083 is registered in ClinicalTrials.gov with All4Cure as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05673083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
Lead sponsor
All4Cure
Phase
Observational
Overall status
Active, not recruiting
Start date
March 1, 2023
Completion date
March 31, 2026
Enrollment
200 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma, multiple myeloma in relapse, multiple myeloma with failed remission, multiple myeloma, refractory